What You Should Know: - Vitestro, the pioneering autonomous blood drawing company, today announced that it has raised $22 million (€20 million) funding to accelerate commercialization of its innovative robotic blood drawing device. - This
Exeliom Biosciences announces three phase II clinical trials in immuno-oncology with lead candidate pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Alpha Mos : BOYDSense completes a EUR 7m capital increase to further develop its non-invasive glucose monitoring device -April 05, 2024 at 02:05 am EDT marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.